BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: C. albicans cytochrome bc1

August 25, 2016 7:00 AM UTC

Mouse, in vitro and cell culture studies identified an indazole-based inhibitor of Candida albicans cytochrome bc1 that could help treat candidiasis resistant to fluconazole and other triazole-based d...